|
1
|
Saulsbury FT: Henoch-Schönlein purpura.
Curr Opin Rheumatol. 13:35–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang YH, Hung CF, Hsu CR, Wang LC, Chuang
YH, Lin YT and Chiang BL: A nationwide survey on epidemiological
characteristics of childhood Henoch-Schönlein purpura in Taiwan.
Rheumatology (Oxford). 44:618–622. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ballinger S: Henoch-Schonlein purpura.
Curr Opin Rheumatol. 15:591–594. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sano H, Izumida M, Shimizu H and Ogawa Y:
Risk factors of renal involvement and significant proteinuria in
Henoch-Schönlein purpura. Eur J Pediatr. 161:196–201. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mills JA, Michel BA, Bloch DA, Calabrese
LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT,
et al: The American College of Rheumatology 1990 criteria for the
classification of Henoch-Schönlein purpura. Arthritis Rheum.
33:1114–1121. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu JJ, Zhu YT and Hu YM: Mechanism of
feedback regulation of neutrophil inflammation in Henoch-Schönlein
purpura. Eur Rev Med Pharmacol Sci. 20:4277–4285. 2016.PubMed/NCBI
|
|
7
|
Knight JF: The rheumatic poison: A survey
of some published investigations of the immunopathogenesis of
Henoch-Schönlein purpura. Pediatr Nephrol. 4:533–541. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng WJ, Chen MG, Chen XY, Yang Q and Lin
RX: Renal expression of macrophage migration inhibitory factor in
children with Henoch-Sch-nlein purpura nephritis. Zhongguo Dang Dai
Er Ke Za Zhi. 12:120–122. 2010.(In Chinese). PubMed/NCBI
|
|
9
|
Wu TH, Wu SC, Huang TP, Yu CL and Tsai CY:
Increased excretion of tumor necrosis factor alpha and interleukin
1 beta in urine from patients with IgA nephropathy and
Schönlein-Henoch purpura. Nephron. 74:79–88. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gattorno M, Vignola S, Barbano G, Sormani
MP, Sabatini F, Buoncompagni A, Picco P and Pistoia V: Tumor
necrosis factor induced adhesion molecule serum concentrations in
Henoch-Schönlein purpura and pediatric systemic lupus
erythematosus. J Rheumatol. 27:2251–2255. 2000.PubMed/NCBI
|
|
11
|
Bradley JR, Lockwood CM and Thiru S:
Endothelial cell activation in patients with systemic vasculitis.
QJM. 87:741–745. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Montefort S, Holgate ST and Howarth PH:
Leucocyte-endothelial adhesion molecules and their role in
bronchial asthma and allergic rhinitis. Eur Respir J. 6:1044–1054.
1993.PubMed/NCBI
|
|
13
|
Rostoker G, Rymer JC, Bagnard G,
Petit-Phar M, Griuncelli M and Pilatte Y: Imbalances in serum
proinflammatory cytokines and their soluble receptors: A putative
role in the progression of idiopathic IgA nephropathy (IgAN) and
Henoch-Schönlein purpura nephritis, and a potential target of
immunoglobulin therapy? Clin Exp Immunol 114: 468–476, 1998? Clin
Exp Immunol 114: 468–476, 1998. 114: 468–476, 1998:468-476,
1998–476, 1998. 1998.
|
|
14
|
Gardner-Medwin JM, Dolezalova P, Cummins C
and Southwood TR: Incidence of Henoch-Schönlein purpura, Kawasaki
disease, and rare vasculitides in children of different ethnic
origins. Lancet. 360:1197–1202. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kimura S, Takeuchi S, Soma Y and Kawakami
T: Raised serum levels of interleukins 6 and 8 and antiphospholipid
antibodies in an adult patient with Henoch-Schönlein purpura. Clin
Exp Dermatol. 38:730–736. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tong YF, Liu Y, Hu ZX, Li ZC and Agula A:
Protocatechuic aldehyde inhibits TNF-α-induced fibronectin
expression in human umbilical vein endothelial cells via a c-Jun
N-terminal kinase dependent pathway. Exp Ther Med. 11:277–282.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
López-Mejías R, Genre F, Pérez BS,
Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Remuzgo-Martínez
S, Mijares V, Pina T, et al: HLA-DRB1 association with
Henoch-Schonlein purpura. Arthritis Rheumatol. 67:823–827. 2014.
View Article : Google Scholar
|
|
18
|
Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ
and Chiang BL: Increased transforming growth factor-beta
(TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody
levels during acute stage of childhood Henoch-Schönlein purpura.
Clin Exp Immunol. 122:285–290. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furukawa S, Matsubara T, Yone K, Hirano Y,
Okumura K and Yabuta K: Kawasaki disease differs from anaphylactoid
purpura and measles with regard to tumour necrosis factor-alpha and
interleukin 6 in serum. Eur J Pediatr. 151:44–47. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Royall JA, Berkow RL, Beckman JS,
Cunningham MK, Matalon S and Freeman BA: Tumor necrosis factor and
interleukin 1 alpha increase vascular endothelial permeability. Am
J Physiol. 257:L399–L410. 1989.PubMed/NCBI
|
